CAPITOL HILL STRATEGIES, LLC for PHRMA
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 9, Innovation Act (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA)). S. 1137, Protecting American Talent and Entrepreneurship Act of 2015 (Inter partes review provisions and other provisions relating to patents covered by Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA)).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner, LD-CongMcIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Medicare/Medicaid MMM
Potential legislation or legislative provisions relating to Medicare Part D and the establishment of a Medicaid style mandatory rebate on prescription drugs) H.R. 2 Medicare Access and CHIP Reauthorization Act of 2015 (potential revenue raising and cost saving provisions) Potential deficit reduction legislation that might include provisions to reduce Medicare Part B reimbursements for drugs and biologics. H.R. 1021, Protecting the Integrity of Medicare Act of 2015 H.R. 1190 - Protecting Seniors Access to Medicare Act of 2015 H.R.2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors of 2015
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner, LD-CongMcIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Medical/Disease Research/Clinical Labs MED
S. 320, The Medical Innovation Act. Legislation to authorize the collection of supplemental payments to increase congressional investments in medical research. H.R. 6, 21st Century Cures Act, (multiple provisions including incentives for innovation to help expedite novel treatments and cures, enhancements to FDA capacity and resources, and promotion of precision therapies, potential offsets)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner, LD-CongMcIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Trade (domestic/foreign) TRD
H.R. 2164 Bipartisan Congressional Trade Priorities and Accountability Act of 2015 H.R. 1295 Trade Preferences Extension Act of 2015 Issues related to the Trans-Pacific Partnership trade agreement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M BRAIN | Asst. to the President, Dp.Chief Staff W&M Cmte |
| HEATHER MCHUGH | Legislative Director, Sen. Chuck Schumer |
| BEAU` SCHUYLER | LD-CongTanner, LD-CongMcIntyre,SA-CongRose |
| A. J. WOJCIAK | Senior Legislative Asst., Cong. Earl Pomeroy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.